Impact of antiplatelet treatment on colorectal cancer staging characteristics

doi:10.4253/wjge.v4.i9.409

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 4, Issue 9

This Article

(0)

(4281)

(8)

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Endoscopy

ISSN

1948-5190

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Brief Article

World J Gastrointest Endosc. Sep 16, 2012; 4(9): 409-413
Published online Sep 16, 2012. doi: 10.4253/wjge.v4.i9.409

Table 1 Number of patients in each group of the study (control - antiplatelet group), the type of therapy, tumor, nodes and metastasis stage (1-4) in each group n (%)

	No. of patients	TNM stage (mean ± SD)
Total	387
Control group	289 (74.6)	2.57 ± 0.96
Antiplatelet group	98 (25.4)	2.27 ± 0.93
Aspirin	65	2.19 ± 0.92
Clopidogrel	17
Ticlopidid	6
Dipyridamole	4
Dual therapy	6

TNM: Tumor, nodes and metastasis staging system of the American Joint Committee on Cancer.

Full Size Table

Citation: Symeonidis D, Koukoulis G, Christodoulidis G, Mamaloudis I, Chatzinikolaou I, Tepetes K. Impact of antiplatelet treatment on colorectal cancer staging characteristics. World J Gastrointest Endosc 2012; 4(9): 409-413
URL: https://www.wjgnet.com/1948-5190/full/v4/i9/409.htm
DOI: https://dx.doi.org/10.4253/wjge.v4.i9.409

Symeonidis D, Koukoulis G, Christodoulidis G, Mamaloudis I, Chatzinikolaou I, Tepetes K. Impact of antiplatelet treatment on colorectal cancer staging characteristics. World J Gastrointest Endosc 2012; 4(9): 409-413 [PMID: 23125899 DOI: 10.4253/wjge.v4.i9.409]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.